Biopharma has begun to exploit the new capability of cryo electron microscopy to deliver high resolution protein structures for non-crystallizable proteins. Drug and biologics design projects are benefitting from this new technology that comprises complex and expensive facilities. How are Massachusetts practitioners navigating this space and implementing workflows?
Join us for this Drug Discovery working group forum exploring where the enterprise of applying cryo electron microscopy stands and what different approaches and experiences there are.